Gnai1 Protein is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
| G Protein Subunit Alpha i1 | |
|---|---|
| Gene Symbol | GNAI1 |
| UniProt ID | P08708 |
| PDB ID | 1BOF, 2GJA, 3MRK |
| Molecular Weight | 40.4 kDa |
| Subcellular Localization | Plasma membrane, cytoplasm |
| Protein Family | Gαi/o family of heterotrimeric G proteins |
| Expression | Brain (cortex, hippocampus, basal ganglia, cerebellum), heart, pancreas |
GNAI1 encodes the Gαi1 subunit, a member of the Gi/o family of heterotrimeric G proteins that inhibit adenylyl cyclase and regulate various downstream effectors.[1] Gαi1 is widely expressed in the nervous system and plays critical roles in modulating neuronal signaling, synaptic transmission, and cellular responses to neurotransmitters. As an inhibitory G protein, GNAI1 couples to GPCRs to suppress cAMP production and activate downstream signaling pathways that influence neuronal excitability, metabolism, and gene expression.
Gαi1 contains the canonical G alpha subunit structure:
Gαi1 cycles between two major conformations:
The intrinsic GTPase activity hydrolyzes GTP to GDP, providing a built-in timer for signal duration.[2]
GNAI1 is expressed throughout the brain:
GNAI1 dysfunction contributes to AD pathogenesis:[3]
| Agent | Target | Status | Indication |
|---|---|---|---|
| Peripartum | Gαi signaling | Research | Various neurological conditions |
| Small molecule modulators | Gαi-GPCR | Preclinical | CNS disorders |
| Disease | Relationship | Evidence |
|---|---|---|
| Alzheimer Disease | cAMP dysregulation, synaptic plasticity | Expression studies |
| Parkinson Disease | D2 receptor signaling | Animal models, postmortem |
| Epilepsy | Neuronal excitability | Genetic studies |
| Schizophrenia | Dopamine signaling | GWAS |
| Depression | cAMP signaling | Clinical studies |
[1] Birnbaumer L, et al. The G protein-coupling of neurotransmitter receptors. Annu Rev Pharmacol Toxicol. 1992;32:167-192. PMID:1318568
[2] Sprang SR. G protein mechanisms: insights from structural analysis. Annu Rev Biochem. 1997;66:639-678. PMID:9242921
[3] Huang W, et al. Gαi1 dysregulation in Alzheimer's disease. J Neurosci. 2020;40(45):8669-8681. PMID:32958752
[4] Nishiyama M, et al. Gαi1 and Gαo1 in dopaminergic neurons. Mol Cell Neurosci. 2019;98:34-47. PMID:31150634
[5] Yuen EY, et al. Gαi1 regulates neuronal excitability and synaptic plasticity. Nat Neurosci. 2018;21(11):1523-1533. PMID:30250264
The study of Gnai1 Protein has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.